Anti-SARS-CoV-2 Potential of Artemisinins In Vitro

Author:

Cao Ruiyuan1,Hu Hengrui23,Li Yufeng23,Wang Xi2,Xu Mingyue23,Liu Jia2,Zhang Huanyu23,Yan Yunzheng1,Zhao Lei1,Li Wei1,Zhang Tianhong14,Xiao Dian1,Guo Xiaojia1,Li Yuexiang1,Yang Jingjing1,Hu Zhihong2ORCID,Wang Manli2,Zhong Wu1ORCID

Affiliation:

1. National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China

2. State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China

3. University of the Chinese Academy of Sciences, Beijing 100049, P. R. China

4. Guoke Excellence (Beijing) Medicine Technology Research Co., Ltd., Beijing 100176, P. R. China

Funder

Ministry of Science and Technology of the People's Republic of China

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Reference33 articles.

1. WHO. (2020) Coronavirus disease (COVID-2019) situation reports - 180. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200718-covid-19-sitrep-180.pdf?sfvrsn=39b31718_2 (accessed on July 21, 2020).

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. National Institutes of Health (2020) Coronavirus Disease 2019 (2019-nCoV) Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ (accessed on June 29, 2020).

4. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

5. Hydroxychloroquine antiparkinsonian potential: Nurr1 modulation versus autophagy inhibition

Cited by 122 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3